EG-1962: Phase III started

Edge began the double-blind, placebo-controlled U.S. Phase III NEWTON 2 trial to compare a single intraventricular injection of 600 mg EG-1962 vs. standard of care (SOC) -- 60 mg oral nimodipine given...